NMPA Approval

Linezolid and Glucose Injection

Approval Number

国药准字HJ20240040

Registration Date

June 11, 2024

Drug Information

Generic Name

利奈唑胺葡萄糖注射液

Dosage Form

注射剂

Strength

300ml：利奈唑胺0.6g与葡萄糖15.0g

Drug Type

化学药品

Registration Date

June 11, 2024

Expiry Date

June 10, 2029

Company Address

61346 Bad Homburg v. d. Höhe Germany

Company Address

Svinesundsveien 80 NO-1788 Halden, Norway

Empowering clinical research with data-driven insights and AI-powered tools.

利奈唑胺葡萄糖注射液 - NMPA 批准文号 | MedPath